Author: tinadickson9
Creative Biolabs Expedites SARS-CoV-2 Subunit Vaccine Development as Variants Arise
As SARS-CoV-2 variants continue to arise and reduce the protection afforded by vaccination or prior infection, Creative Biolabs deploys subunit vaccine development solutions targeting more conserved regions of the SARS-CoV-2 spike (S) protein. Recent research described that S2-targeted vaccination induced the production of antibodies in mice that could neutralize diverse alphacoronaviruses and betacoronaviruses. It indicates that subunit vaccine design for SARS-CoV-2 targeting more conserved regions of the spike protein may be a strategy to achieve pan-SARS-CoV-2 immunity. In order to help researchers get prepared as emerging SARS-CoV-2 variants are revealed to reduce existing vaccination effectiveness, Creative Biolabs deploys comprehensive recombinant S protein ... Read more